Why Catalent?

With more than 30 years of experience in biologics services and partnerships with more than 20 premier gene therapy companies, Catalent is your trusted gene therapy CDMO partner for custom viral vector development and scalable manufacturing of adeno-associated virus (AAV) vectors, next-generation vaccines, and oncolytic viruses. We have experience with more than 60 gene therapy programs across various stages of development, a commercially approved manufacturing facility, and a total plasmid and gene therapy footprint of 600,000+ square feet. Let our Gene Therapy experts create a custom, scalable solution for your next groundbreaking therapeutic.

Learn about our Harmans/BWI commercial facility receiving FDA approval.